ik heb ze nog altijd in portefeuille.
Iemand nog nieuws ?

ja dit : http://www.smarteranalyst.com/2014/07/0 ... -pt-to-28/" onclick="window.open(this.href);return false;
Bijhouden is dus meer dan aangewezen !

gene paniek dit is gewoon kuddegeest ZONDER reden ....

http://finance.yahoo.com/news/durata-th ... 00903.html

Buy! buy!

Frank Frazzano schreef het volgende :
Durata Therapeutics Inc.'s ( DRTX ) Dutch subsidiary, Durata Therapeutics International B.V., has entered into a license and supply agreement with privately-held Italian drugmaker Angelini to commercialize its antibiotic Dalbavancin in 36 countries, which include Italy, Spain, Poland, Portugal, many Eastern European countries, Russia, Turkey, and Commonwealth of Independent States.

According to the terms of the agreement, Durata will receive an upfront payment from Angelini of $15 million and another $10 million upon European Medicines Agency approval. The company will also receive payments upon the achievement of certain countries' pricing approvals and sales milestones, as well as royalties on sales.

Durata's Marketing Authorization Application for Dalbavancin is under review with the European Medicines Agency and a decision is expected in the first half of 2015.

DRTX closed Wednesday's trading at $13.17, up 2.89%.

...I remain LONG 3236 shares and this stock was selling at $18 just a couple weeks ago when they recvd APPROVAL to ship/sell Dalbavancin in the US....this antibiotic is likely to REPLACE much of Vancomycin IV in the Hospital because of resistance to Vanco and required daily dosing which Dalba can be dosed in the ER at 1000 mgs and 7 days later in clinic and a #$%$ dose of 500mgs...so two doses in 7 days instead of DAILY admitted in the hospital dosing..this is a huge SAVINGS to the Hospital and will also REWARD the Hospital on LESS TX failure to Vanco....remember that today when you FAIL TO CURE AN INFECTION...you are NOT REIMBURSED!!!

Dalba will insure Reimbursement because almost no Staph including MRSA is resistant..also they are studying a Single 1500mg dose now....thats the Future!

So we will get Sales numbers of Launch in October/November and now is the time to accumulate!

Fraz

Blijkbaar is het idd tijd om bij te kopen !

Seperately, AstraZeneca was among the companies speculated to be interested in Durata Therapeutics, a US-listed superbug antibiotic developer. Takeover gossip led Durata shares to jump on Monday, giving the group a market value of about $385m.

http://www.ft.com/cms/s/0/4542ab38-1bf7 ... abdc0.html" onclick="window.open(this.href);return false;

eindelijk het nieuws waarop we zaten te wachten : http://finance.yahoo.com/news/fda-grant ... 00500.html" onclick="window.open(this.href);return false;

Insider, dat komt in de saccoche !

Pre-market: +77,23%. Wow !!!
Hallo insider ??

HET SPEL IS GESPEELD !!!!!!!!!!!! DRTX is overgenomen !
sorry dat ik wat laat reageerde Evita maar is was van mijne sus gedraaid ! LOL !
http://seekingalpha.com/news/2015905-ac ... buy-durata" onclick="window.open(this.href);return false;

@ insider
Proficiat.
Had ze niet. Kan niet alles hebben
Hopelijk heeft één van je andere aandelen hetzelfde voor, want zit wel in sommige van hen ....

ja ik heb nog ARDM (kleine restpositie behouden) en POZN (klein verlies) dus ....

Insider, moet ik nu al verkopen ?

de mijne zijn al buiten vanaf het begin van de beursdag aan $24 dus .... JA ! alles wat boven $23 ligt is extra winst !

Mijn aandelen liggen buiten aan 23,59 $ !